NC

Navin Chandra Pathak

Active Director Director DIN 07119519
DIN 07119519 First appointment Mar 2015 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Navin Chandra Pathak

Data last updated:

Navin Chandra Pathak is a Director at Denlay Pharma Private Limited (since 2015). The company operates in Professional Services. Denlay Pharma Private Limited reported revenue of ₹25,470 (FY 2025).

DIN 07119519
Primary Designation Director
Industry Professional Services
First Appointment 27 Mar 2015
Oldest Company Age 11 yrs
Largest company Denlay Pharma Private Limited · ₹25,470 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Denlay Pharma Private Limited U74120UP2015PTC069818
Director27 Mar 20152015₹25,470 (FY 2025)Active

Board colleagues of Navin Chandra Pathak

NameDINCompanyDesignation
Nazar Hasan Khan07119524Denlay Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Denlay Pharma Private Limited
Premium access

Shareholding and investment profile for Navin Chandra Pathak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navin Chandra Pathak

Navin Chandra Pathak currently holds 1 directorship: Denlay Pharma Private Limited (Director, since 27 Mar 2015, revenue ₹25,470 (FY 2025)).

Navin Chandra Pathak was first appointed on 27 Mar 2015 as Director at Denlay Pharma Private Limited.

The current boards of Navin Chandra Pathak's companies include Nazar Hasan Khan (Denlay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available